-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Haili Biotech (603718.SH) announced that the company's holding subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (“Ruisheng Biotech”) submitted registration information for Ruisheng Biotech's GORORISE Natural Bone Grafting Material (GORORISE natural bone grafting material) products to the Indonesian Ministry of Health (“MOH”) in August 2025. Ruisheng Biotech recently received a MOH notice, and Ruisheng Biotech's GORORISE natural bone graft material product was approved by MOH.

Zhitongcaijing·12/16/2025 09:01:06
Listen to the news
Zhitong Finance App News, Haili Biotech (603718.SH) announced that the company's holding subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (“Ruisheng Biotech”) submitted registration information for Ruisheng Biotech's GORORISE Natural Bone Grafting Material (GORORISE natural bone grafting material) products to the Indonesian Ministry of Health (“MOH”) in August 2025. Ruisheng Biotech recently received a MOH notice, and Ruisheng Biotech's GORORISE natural bone graft material product was approved by MOH.